2256084-03-2
2256084-03-2 structure
- Name: Sugemalimab
- Chemical Name: Sugemalimab
- CAS Number: 2256084-03-2
- Molecular Formula:
- Molecular Weight:
- Catalog: Signaling Pathways Immunology/Inflammation PD-1/PD-L1
- Create Date: 2022-08-16 20:01:07
- Modify Date: 2025-08-31 20:20:10
-
Sugemalimab is a fully human, full length, anti-programmed death ligand 1 (PD-L1) immunoglobulin G4 (IgG4) monoclonal antibody (mAb). Sugemalimab shows anticancer activities and can be used for non-small cell lung cancer research[1].
| Name | Sugemalimab |
|---|
| Description | Sugemalimab is a fully human, full length, anti-programmed death ligand 1 (PD-L1) immunoglobulin G4 (IgG4) monoclonal antibody (mAb). Sugemalimab shows anticancer activities and can be used for non-small cell lung cancer research[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Dhillon S, et al. Sugemalimab: First Approval. Drugs. 2022 Apr;82(5):593-599. |
| No Any Chemical & Physical Properties |